Tonix Pharmaceuticals Inc. has gained a reputation for moving to market faster than traditional drug developers. According to CEO Seth Lederman, a New York City headquarters had a lot to do with it.
Even though Manhattan doesn’t have the same biotech bragging rights as, say, Boston, Lederman argues that the Tonix (Nasdaq: TNXP) did just fine in midtown.
